Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, NY.

Iregui A, Khan Z, Malik S, Landman D, Quale J.

Clin Infect Dis. 2019 Aug 15. pii: ciz787. doi: 10.1093/cid/ciz787. [Epub ahead of print]

PMID:
31412357
2.

Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres.

Khan Z, Iregui A, Landman D, Quale J.

J Antimicrob Chemother. 2019 Jul 11. pii: dkz294. doi: 10.1093/jac/dkz294. [Epub ahead of print]

PMID:
31298277
3.

In Vitro and In Vivo Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant Acinetobacter baumannii.

Rose M, Lapuebla A, Landman D, Quale J.

Microb Drug Resist. 2019 Apr 22. doi: 10.1089/mdr.2018.0179. [Epub ahead of print]

PMID:
31009322
4.

Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges.

Iregui A, Ha K, Meleney K, Landman D, Quale J.

J Antimicrob Chemother. 2018 Nov 1;73(11):2997-3000. doi: 10.1093/jac/dky322.

PMID:
30107491
5.

Effect of Porins and blaKPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?

Balabanian G, Rose M, Manning N, Landman D, Quale J.

Microb Drug Resist. 2018 Sep;24(7):877-881. doi: 10.1089/mdr.2018.0065. Epub 2018 May 21.

PMID:
29782237
6.

Perirectal Screening for Carbapenem-Resistant Enterobacteriaceae Obtained From 100 Consecutive Healthy Pregnant Women in Labor at a Brooklyn Hospital: Results and Risk Factors.

Rawstron SA, Jackman JM, Serebro E, Johnson G, Cabbad M, Bromberg K, Kondamudi V, Sepkowitz D, Landman D.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):369-371. doi: 10.1017/ice.2017.295. Epub 2018 Jan 23. No abstract available.

PMID:
29357953
7.

Group B Streptococcal Tricuspid Endocarditis: Case Report and Systematic Review.

Wengrofsky P, Mubarak G, Khondakar N, Haseeb S, Landman D, Graham-Hill S, Zhyvotovska A, McFarlane SI.

Scifed J Cardiol. 2018;2(4). pii: 22. Epub 2018 Dec 18.

8.

In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae.

Nath S, Moussavi F, Abraham D, Landman D, Quale J.

J Antimicrob Chemother. 2018 Feb 1;73(2):431-436. doi: 10.1093/jac/dkx419.

PMID:
29186402
9.

Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.

Manning N, Balabanian G, Rose M, Landman D, Quale J.

Microb Drug Resist. 2018 Jan/Feb;24(1):35-39. doi: 10.1089/mdr.2016.0293. Epub 2017 Jun 7.

PMID:
28590820
10.

Rise and fall of KPC-producing Klebsiella pneumoniae in New York City.

Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Ghitan M, Collins B, Bratu S, Quale J.

J Antimicrob Chemother. 2016 Oct;71(10):2945-8. doi: 10.1093/jac/dkw242. Epub 2016 Jun 26.

PMID:
27353464
11.

Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City.

Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Quale J, Landman D.

Antimicrob Agents Chemother. 2015 Aug;59(8):4856-60. doi: 10.1128/AAC.00843-15. Epub 2015 Jun 1.

12.

Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City.

Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J.

Antimicrob Agents Chemother. 2015 Aug;59(8):5029-31. doi: 10.1128/AAC.00830-15. Epub 2015 May 26.

13.

Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City.

Abdallah M, Olafisoye O, Cortes C, Urban C, Charles C, Landman D, Quale J.

Am J Infect Control. 2015 Jun;43(6):650-2. doi: 10.1016/j.ajic.2015.02.018. Epub 2015 Mar 26.

PMID:
25818022
14.

Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City.

Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J.

Antimicrob Agents Chemother. 2015 Mar;59(3):1802-5. doi: 10.1128/AAC.04809-14. Epub 2014 Dec 22.

15.

In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.

Landman D, Singh M, El-Imad B, Miller E, Win T, Quale J.

Int J Antimicrob Agents. 2014 Jun;43(6):527-32. doi: 10.1016/j.ijantimicag.2014.02.017. Epub 2014 Apr 13.

PMID:
24796217
16.

Are community environmental surfaces near hospitals reservoirs for gram-negative nosocomial pathogens?

Rose M, Landman D, Quale J.

Am J Infect Control. 2014 Apr;42(4):346-8. doi: 10.1016/j.ajic.2013.12.025.

PMID:
24679558
17.

Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes.

Landman D, Salamera J, Quale J.

J Clin Microbiol. 2013 Dec;51(12):4106-11. doi: 10.1128/JCM.02129-13. Epub 2013 Oct 2.

18.

Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.

Landman D, Babu E, Shah N, Kelly P, Olawole O, Bäcker M, Bratu S, Quale J.

J Antimicrob Chemother. 2012 Jun;67(6):1427-31. doi: 10.1093/jac/dks063. Epub 2012 Feb 29.

PMID:
22378678
19.

Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.

Quale J, Shah N, Kelly P, Babu E, Backer M, Rosas-Garcia G, Salamera J, George A, Bratu S, Landman D.

Microb Drug Resist. 2012 Apr;18(2):132-6. doi: 10.1089/mdr.2011.0163. Epub 2011 Dec 23.

PMID:
22196342
20.

Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints.

Landman D, Salamera J, Singh M, Quale J.

J Clin Microbiol. 2011 Nov;49(11):3931-3. doi: 10.1128/JCM.01176-11. Epub 2011 Aug 31.

21.

Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.

Landman D, Kelly P, Bäcker M, Babu E, Shah N, Bratu S, Quale J.

J Antimicrob Chemother. 2011 Feb;66(2):332-4. doi: 10.1093/jac/dkq459. Epub 2010 Dec 3.

PMID:
21131322
22.

Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Landman D, Urban C, Bäcker M, Kelly P, Shah N, Babu E, Bratu S, Quale J.

J Clin Microbiol. 2010 Dec;48(12):4604-7. doi: 10.1128/JCM.01143-10. Epub 2010 Oct 6.

23.

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.

Landman D, Babu E, Shah N, Kelly P, Bäcker M, Bratu S, Quale J.

J Antimicrob Chemother. 2010 Oct;65(10):2123-7. doi: 10.1093/jac/dkq278. Epub 2010 Jul 28.

PMID:
20667885
24.

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.

Landman D, Bratu S, Quale J.

J Med Microbiol. 2009 Oct;58(Pt 10):1303-8. doi: 10.1099/jmm.0.012575-0. Epub 2009 Jun 25.

25.

Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City.

Bratu S, Landman D, George A, Salvani J, Quale J.

J Antimicrob Chemother. 2009 Aug;64(2):278-83. doi: 10.1093/jac/dkp186. Epub 2009 May 20.

26.

Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.

Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J.

Infect Control Hosp Epidemiol. 2009 May;30(5):447-52. doi: 10.1086/596734.

PMID:
19301985
27.

Polymyxins revisited.

Landman D, Georgescu C, Martin DA, Quale J.

Clin Microbiol Rev. 2008 Jul;21(3):449-65. doi: 10.1128/CMR.00006-08. Review.

28.

Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City.

Bratu S, Landman D, Martin DA, Georgescu C, Quale J.

Antimicrob Agents Chemother. 2008 Sep;52(9):2999-3005. doi: 10.1128/AAC.01684-07. Epub 2008 Jun 30.

29.

Genetic relatedness of multidrug-resistant Acinetobacter baumannii endemic to New York City.

Landman D, Butnariu M, Bratu S, Quale J.

Epidemiol Infect. 2009 Feb;137(2):174-80. doi: 10.1017/S0950268808000824. Epub 2008 May 27.

PMID:
18503729
30.

Role of AmpD, OprF and penicillin-binding proteins in beta-lactam resistance in clinical isolates of Pseudomonas aeruginosa.

Bratu S, Landman D, Gupta J, Quale J.

J Med Microbiol. 2007 Jun;56(Pt 6):809-14.

PMID:
17510267
31.

Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.

Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, Quale J.

J Antimicrob Chemother. 2007 Jul;60(1):78-82. Epub 2007 May 9.

PMID:
17490999
32.

Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.

Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J.

Clin Infect Dis. 2007 Apr 1;44(7):972-5. Epub 2007 Feb 21.

PMID:
17342651
33.

A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City.

Bratu S, Landman D, Gupta J, Trehan M, Panwar M, Quale J.

Ann Clin Microbiol Antimicrob. 2006 Nov 30;5:29.

34.

Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Quale J, Bratu S, Gupta J, Landman D.

Antimicrob Agents Chemother. 2006 May;50(5):1633-41.

35.
36.

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J.

Arch Intern Med. 2005 Jun 27;165(12):1430-5.

PMID:
15983294
37.

Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, Karumudi U, Tolaney P, Quale J.

Antimicrob Agents Chemother. 2005 Jul;49(7):3018-20.

38.

Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units.

Bratu S, Eramo A, Kopec R, Coughlin E, Ghitan M, Yost R, Chapnick EK, Landman D, Quale J.

Emerg Infect Dis. 2005 Jun;11(6):808-13.

39.

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.

Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D.

J Antimicrob Chemother. 2005 Jul;56(1):128-32. Epub 2005 May 25.

PMID:
15917285
40.

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.

Landman D, Bratu S, Alam M, Quale J.

J Antimicrob Chemother. 2005 Jun;55(6):954-7. Epub 2005 May 9.

PMID:
15883174
41.

Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B.

Bratu S, Quale J, Cebular S, Heddurshetti R, Landman D.

Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):196-201.

PMID:
15772821
42.

Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York.

Bratu S, Landman D, Alam M, Tolentino E, Quale J.

Antimicrob Agents Chemother. 2005 Feb;49(2):776-8.

43.

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, Rahal JJ, Brooks S, Cebular S, Quale J.

Clin Infect Dis. 2004 Jul 1;39(1):55-60. Epub 2004 Jun 14.

PMID:
15206053
44.

Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City.

Quale J, Bratu S, Landman D, Heddurshetti R.

Clin Infect Dis. 2003 Jul 15;37(2):214-20. Epub 2003 Jul 9.

PMID:
12856214
45.

Molecular epidemiology of oxacillin-resistant Staphylococcus aureus in Brooklyn, New York.

Landman D, Bratu S, Flores C, Sathe S, Maccario E, Ravishankar J, Quale J.

Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):58-61. Epub 2003 Jan 18.

PMID:
12582747
46.

Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.

Quale JM, Landman D, Bradford PA, Visalli M, Ravishankar J, Flores C, Mayorga D, Vangala K, Adedeji A.

Clin Infect Dis. 2002 Oct 1;35(7):834-41. Epub 2002 Sep 10.

PMID:
12228820
47.

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S.

Arch Intern Med. 2002 Jul 8;162(13):1515-20.

PMID:
12090889
48.

Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep.

Quale J, Landman D, Ravishankar J, Flores C, Bratu S.

Emerg Infect Dis. 2002 Jun;8(6):594-7.

49.
50.

Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.

Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J.

Clin Infect Dis. 2000 Jul;31(1):101-6. Epub 2000 Jul 17.

PMID:
10913404

Supplemental Content

Loading ...
Support Center